Medical Equipment

Global Transcatheter Mitral Valve Market Size Projected to Reach $2.28 Billion During the Forecast Period

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Transcatheter Mitral Valve Industry Compare Between 2025 And 2029?

The transcatheter mitral valve market has experienced robust expansion in recent years. This market is expected to grow from $1.47 billion in 2024 to $1.61 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.5%. The notable growth observed historically stems from the rising adoption of minimally invasive cardiac surgeries, successful outcomes in clinical trials for initial TMVR devices, the enhancement of hospital infrastructure in developed regions, an increase in the prevalence of rheumatic heart disease in low-income nations, and the expansion of training programs designed for interventional cardiologists.

The transcatheter mitral valve market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $2.28 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.1%. Several factors will fuel this growth during the forecast period. These include a rising preference for catheter-based treatments among younger demographics, an expanding array of advanced transcatheter mitral valve replacement products in development, enhanced emphasis on early detection via artificial intelligence-powered imaging, an increasing number of regulatory clearances for TMV devices, and the incorporation of real-time navigation and imaging systems into transcatheter mitral valve interventions. Key trends expected over the forecast period encompass improvements in artificial intelligence-driven imaging for evaluating valves, the application of advanced material coatings to boost biocompatibility, the creation of customized transcatheter mitral valve solutions utilizing 3D printing, advancements in the flexibility and accuracy of delivery catheters, and the adoption of digital twin technology for meticulous procedural planning.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27437&type=smp

What Are The Main Drivers Boosting The Transcatheter Mitral Valve Industry’s Expansion?

The escalating incidence of cardiac conditions is projected to stimulate the expansion of the transcatheter mitral valve market in the coming years. Heart diseases are impairments that disrupt the heart’s structure or function, thereby diminishing its efficiency in pumping blood. The increasing occurrence of heart diseases is primarily influenced by aging populations, as the age-related deterioration of the heart and blood vessels heightens vulnerability to conditions such as mitral valve regurgitation, heart failure, and arrhythmias. A transcatheter mitral valve assists in treating heart disease by repairing or replacing a damaged mitral valve to re-establish healthy blood flow between the heart’s chambers, improving cardiac performance and easing symptoms. For instance, in October 2024, information from the Centers for Disease Control and Prevention, a US-based government agency, indicated that in 2022, coronary heart disease was the most widespread form of heart disease, leading to 371,506 deaths. Annually in the United States, approximately 805,000 individuals experience a heart attack, with new cases (605,000) occurring nearly three times more often than recurring cases (200,000). Thus, the growing prevalence of heart diseases is fueling the growth of the transcatheter mitral valve market.

What Are The Different Segment Classifications Within The Transcatheter Mitral Valve Market?

The transcatheter mitral valve market covered in this report is segmented

1) By Product: Transcatheter Mitral Valve Replacement, Transcatheter Mitral Valve Repair

2) By Indication: Mitral Stenosis, Mitral Regurgitation

3) By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories

Subsegments:

1) By Transcatheter Mitral Valve Replacement: Self-Expanding Valves, Balloon-Expandable Valves

2) By Transcatheter Mitral Valve Repair: Annuloplasty Devices, Chordal Repair Devices, Edge-To-Edge Repair Devices

What Trends Are Redefining The Transcatheter Mitral Valve Market Dynamics?

Leading companies in the transcatheter mitral valve market are concentrating on developing advanced products, such as transcatheter mitral valve replacement systems, to broaden treatment options for high-risk or inoperable patients. Transcatheter mitral valve replacement (TMVR) systems denote a minimally invasive medical device that substitutes a damaged or diseased mitral valve in the heart with an artificial valve using a catheter-based approach, thereby avoiding the necessity for open-heart surgery. For example, in May 2025, Abbott Laboratories, a US-based medical device company, introduced Tendyne, which gained approval from the Food and Drug Administration (FDA). It is a self-expanding, nitinol-framed valve offered in multiple sizes to accommodate diverse anatomies and can be entirely repositioned or retrieved during implantation. Delivered via a small incision in the chest, the system facilitates a minimally invasive procedure typically finished in about 1.5 hours. Designed for expedited recovery, the system enables most patients to be discharged within three days, presenting a transformative solution for high-risk mitral valve patients who lack viable surgical alternatives.

Which Leading Companies Dominate The Transcatheter Mitral Valve Market Share?

Major companies operating in the transcatheter mitral valve market are Abbott Laboratories, Medtronic Inc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Private Limited, MicroPort Scientific Corporation, Venus Medtech Inc., Cardiac Dimensions Inc., JenaValve Technology Inc., Ancora Heart Inc, Peijia Medical Limited, Micro Interventional Devices Inc., 4C Medical Technologies Inc., NeoChord Inc., Xeltis AG, Valcare Medical Inc., Colibri Heart Valve LLC, MitrAssist Ltd., HighLife SAS, Navigate Cardiac Structures Inc., Cardiovalve Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/transcatheter-mitral-valve-global-market-report

How Do Regional Market Performances Compare Within The Transcatheter Mitral Valve Industry?

North America was the largest region in the transcatheter mitral valve market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter mitral valve market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Transcatheter Mitral Valve Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27437&type=smp

Browse Through More Reports Similar to the Global Transcatheter Mitral Valve Market 2025, By The Business Research Company

Nanomaterials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nanomaterials-global-market-report

Titanium Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/titanium-global-market-report

Carbon Nanomaterials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/carbon-nanomaterials-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795